Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Verastem, Inc.VSTM · Entity 5242 | Director · President and CEO | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Verastem, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 652,712 |
Ending reported balance
After 2026-10-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-30 · Grant · Disposed 106,893 · Balance 696,833 F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved. Row 2 · 2026-10-01 · Sale · Disposed 44,121 · Balance 652,712 F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved.
F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 01:15 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 44,121 | $8.00 | $352,968.00 |
DisclosureSEC source: 0001104659-26-113362 · tm2626963-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 652,712 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:15 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 106,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-113362 · tm2626963-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 696,833 F1 · shares: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:37 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 1,302 | $5.81 | $7,564.62 |
DisclosureSEC source: 0001104659-26-091172 · tm2622308-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 589,940 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:45 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 20,871 | $4.18 | $87,240.78 |
DisclosureSEC source: 0001104659-26-077333 · tm2618883-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 591,242 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:01 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 806 | $5.82 | $4,690.92 |
DisclosureSEC source: 0001104659-26-056226 · tm2613656-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 612,113 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 21:10 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 970 | $6.69 | $6,489.30 |
DisclosureSEC source: 0001104659-26-010891 · tm265273-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 612,919 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 21:57 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 213,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-006279 · tm263949-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,889 F1 · shares: Restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of January 21, 2026 such that the award is fully vested on January 21, 2029 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 10,321 | $7.16 | $73,898.36 |
DisclosureSEC source: 0001104659-26-003789 · tm263206-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,104 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 21:46 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 393 | $9.14 | $3,592.02 |
DisclosureSEC source: 0001104659-25-122578 · tm2533899-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,425 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 22:06 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-120709 · tm2533371-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 22:06 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.07 | $20,140.00 |
DisclosureSEC source: 0001104659-25-120709 · tm2533371-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 09, 2025 Filed Dec 9, 2025 22:03 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.25 | $20,500.00 |
DisclosureSEC source: 0001104659-25-119712 · tm2533088-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 414,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 22:03 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.50 | $21,000.00 |
DisclosureSEC source: 0001104659-25-119712 · tm2533088-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 416,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 22:03 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.61 | $21,220.00 |
DisclosureSEC source: 0001104659-25-119712 · tm2533088-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 418,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 04, 2025 Filed Dec 4, 2025 21:54 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-118490 · tm2532778-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 420,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:54 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-118490 · tm2532778-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:54 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.32 | $20,640.00 |
DisclosureSEC source: 0001104659-25-118490 · tm2532778-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 424,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 21:40 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.39 | $20,780.00 |
DisclosureSEC source: 0001104659-25-117345 · tm2532479-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:40 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.79 | $21,580.00 |
DisclosureSEC source: 0001104659-25-117345 · tm2532479-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 428,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:40 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.32 | $20,640.00 |
DisclosureSEC source: 0001104659-25-117345 · tm2532479-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 430,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 22:32 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-116059 · tm2532206-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 22:32 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-116059 · tm2532206-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 434,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:32 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-116059 · tm2532206-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 436,818 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 17:21 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001104659-25-107585 · tm2530382-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,818 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 03, 2025 Filed Nov 6, 2025 17:21 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 1,299 | $9.35 | $12,145.65 |
DisclosureSEC source: 0001104659-25-107585 · tm2530382-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,818 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 22:11 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 390 | $9.99 | $3,896.10 |
DisclosureSEC source: 0001104659-25-091360 · tm2526484-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 442,117 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| August 06, 2025 Filed Aug 7, 2025 00:38 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 1,332 | $5.81 | $7,738.92 |
DisclosureSEC source: 0001104659-25-074843 · tm2522778-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 442,507 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:39 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 17,808 | $5.13 | $91,355.04 |
DisclosureSEC source: 0001104659-25-062131 · tm2518795-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 443,839 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 16, 2025 Filed Jun 20, 2025 15:22 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 335 | $5.65 | $1,892.75 |
DisclosureSEC source: 0001104659-25-061041 · tm2518337-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,647 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 20, 2025 Filed May 20, 2025 23:52 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 58,677 | $8.13 | $477,044.01 |
DisclosureSEC source: 0001104659-25-051161 · tm2515719-1_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 461,982 F3 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:52 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-051161 · tm2515719-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 520,659 F2 · shares: The reported securities were subject to a performance RSU award that was granted on June 18, 2024. 150,000 RSUs vested on May 16, 2025, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria of approval by the FDA of an NDA for the Company's combination therapy of avutometinib and defactinib for the treatment of low-grade serous ovarian cancer had occurred. Read SEC document |
| May 16, 2025 Filed May 20, 2025 23:52 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-051161 · tm2515719-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 370,659 F1 · shares: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on August 2, 2023. 25,000 RSUs vested on May 16, 2025, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria of approval by the U.S. Food and Drug Administration (the "FDA") of a new drug application ("NDA") for a product which contains avutometinib in combination with defactinib had occurred. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 820 | $7.30 | $5,986.00 |
DisclosureSEC source: 0001104659-25-045570 · tm2514367-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,659 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 20:48 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 244 | $6.95 | $1,695.80 |
DisclosureSEC source: 0001104659-25-025612 · tm259809-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,479 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 858 | $5.70 | $4,890.60 |
DisclosureSEC source: 0001104659-25-009693 · tm255621-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,723 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 8,568 | $5.24 | $44,896.32 |
DisclosureSEC source: 0001104659-25-003458 · tm253202-3_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,581 F3 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of the performance-based restricted stock units. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003458 · tm253202-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,149 F2 · shares: The reported securities were subject to a performance RSU award that was granted on August 2, 2023. 25,000 RSUs vested on January 10, 2025 upon the Issuer's board of directors determining the performance criteria of acceptance of a new drug application for a product which contains avutometinib in combination with defactinib by the U.S. Food and Drug Administration had occurred. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-003458 · tm253202-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,149 F1 · shares: Restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of January 10, 2025 (the "RSU Grant Date") such that the award is fully vested on January 10, 2028 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 183 | $4.37 | $799.71 |
DisclosureSEC source: 0001104659-24-130841 · tm2431760-1_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,149 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 20, 2024 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 244 | $4.54 | $1,107.76 |
DisclosureSEC source: 0001104659-24-130841 · tm2431760-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,332 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 812 | $3.84 | $3,118.08 |
DisclosureSEC source: 0001104659-24-115341 · tm2427846-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,576 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 19, 2024 Filed Sep 20, 2024 22:01 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 184 | $2.79 | $513.36 |
DisclosureSEC source: 0001104659-24-101765 · tm2424483-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,388 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 20:30 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 246 | $2.80 | $688.80 |
DisclosureSEC source: 0001104659-24-100986 · tm2424302-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,572 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:18 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 3,245 | $2.16 | $7,009.20 |
DisclosureSEC source: 0001104659-24-086773 · tm2421102-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,818 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 00:28 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 183 | $3.21 | $587.43 |
DisclosureSEC source: 0001104659-24-073602 · tm2417704-2_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,063 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units ("RSUs"). Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 00:28 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-073602 · tm2417704-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,246 F2 · shares: RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of June 18, 2024 (the "RSU Grant Date") such that the award is fully vested on June 18, 2027 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| June 17, 2024 Filed Jun 21, 2024 00:28 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 244 | $3.49 | $851.56 |
DisclosureSEC source: 0001104659-24-073602 · tm2417704-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,246 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 21:34 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 182 | $10.38 | $1,889.16 |
DisclosureSEC source: 0001104659-24-036790 · tm249354-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,490 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 21:34 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 244 | $10.71 | $2,613.24 |
DisclosureSEC source: 0001104659-24-036790 · tm249354-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,672 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (right to buy) · Derivative | 23,843 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 14 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,843 Underlying: Common Stock · 23,843 shares Expires 2034-03-11 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.